Instrument Inactif

Communiqués CURE Pharmaceutical Holding Corp. Other OTC

Actions

CURR

US23127P1049

Logiciels

Communiqués

09/10/24	Avenir Wellness : Amendment to Quarterly Report Form 10 Q/A	PU
02/10/24	CURE Pharmaceutical Appoints Raymond Watt to Board of Directors	AQ
16/08/23	Avenir Wellness Solutions Reports Second Quarter 2023 Results	AQ
01/08/23	Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year over Year Revenue Increases and Continued High Gross Margins	AQ
22/05/23	AVENIR WELLNESS SOLUTIONS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/04/23	AVENIR WELLNESS SOLUTIONS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
19/04/23	AVENIR WELLNESS SOLUTIONS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
08/03/23	AVENIR WELLNESS SOLUTIONS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
17/01/23	AVENIR WELLNESS SOLUTIONS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
21/11/22	CURE PHARMACEUTICAL HOLDING CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
11/11/22	Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference	NE
24/10/22	Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV	NE
05/09/22	Cure Pharmaceutical Reports Second Quarter 2022 Results with Increased Sequential Revenues and Strong Margins	AQ
02/09/22	CURE PHARMACEUTICAL HOLDING CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
02/09/22	Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins	GL
02/09/22	Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins	AQ
19/08/22	CURE PHARMACEUTICAL HOLDING CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
16/08/22	CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman	GL
16/08/22	CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman	AQ
09/08/22	CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call	AQ
09/08/22	CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call	GL
02/08/22	CURE Pharmaceutical Announces the Appointment of New Board Member	AQ
02/08/22	CURE Pharmaceutical Announces the Appointment of New Board Member	GL
01/08/22	CURE Pharmaceutical Announces Teleconference With Investors	GL
28/07/22	CURE PHARMACEUTICAL HOLDING CORP. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ